| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.18e-08 | 37 | 41 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.35e-08 | 38 | 41 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.24e-04 | 11 | 41 | 2 | GO:0004523 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.29e-04 | 430 | 41 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | peptidase activity | 3.34e-04 | 654 | 41 | 7 | GO:0008233 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.69e-04 | 14 | 41 | 2 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 8.43e-04 | 21 | 41 | 2 | GO:0035613 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.05e-03 | 891 | 41 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 2.54e-03 | 1189 | 41 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.62e-03 | 37 | 41 | 2 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.76e-03 | 38 | 41 | 2 | GO:0034061 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.82e-03 | 288 | 41 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.02e-03 | 46 | 41 | 2 | GO:0016893 | |
| GeneOntologyMolecularFunction | protein phosphatase inhibitor activity | 4.73e-03 | 50 | 41 | 2 | GO:0004864 | |
| GeneOntologyMolecularFunction | phosphatase inhibitor activity | 5.50e-03 | 54 | 41 | 2 | GO:0019212 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 4.15e-07 | 85 | 37 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 4.15e-07 | 85 | 37 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 5.22e-07 | 89 | 37 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | viral process | 1.60e-05 | 464 | 37 | 7 | GO:0016032 | |
| MousePheno | absent subplate | 2.49e-05 | 4 | 29 | 2 | MP:0008443 | |
| Domain | NAP | 5.10e-04 | 17 | 37 | 2 | PF00956 | |
| Domain | NAP_family | 5.10e-04 | 17 | 37 | 2 | IPR002164 | |
| Domain | Gal_Oxidase_b-propeller | 2.06e-03 | 34 | 37 | 2 | IPR015916 | |
| Domain | - | 4.07e-03 | 48 | 37 | 2 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 5.31e-03 | 55 | 37 | 2 | IPR015915 | |
| Domain | Kelch | 5.89e-03 | 58 | 37 | 2 | SM00612 | |
| Pubmed | 8.17e-10 | 12 | 41 | 4 | 14557543 | ||
| Pubmed | 3.03e-08 | 6 | 41 | 3 | 15063128 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 8.99e-08 | 94 | 41 | 5 | 21542922 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21081508 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 19028687 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.36e-06 | 2 | 41 | 2 | 9460924 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 2.26e-06 | 180 | 41 | 5 | 30110629 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 10516026 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 9971820 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 7983737 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.35e-05 | 5 | 41 | 2 | 12629516 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 12970426 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 6.84e-05 | 1201 | 41 | 8 | 35696571 | |
| Pubmed | 1.13e-04 | 79 | 41 | 3 | 14729942 | ||
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 18664271 | ||
| Pubmed | 2.39e-04 | 1440 | 41 | 8 | 30833792 | ||
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 2.41e-04 | 258 | 41 | 4 | 21081666 | |
| Pubmed | 4.67e-04 | 27 | 41 | 2 | 11463741 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 7.14e-04 | 344 | 41 | 4 | 30333137 | |
| Pubmed | 7.72e-04 | 152 | 41 | 3 | 16009940 | ||
| Pubmed | 7.87e-04 | 153 | 41 | 3 | 10718198 | ||
| Pubmed | 8.65e-04 | 1335 | 41 | 7 | 29229926 | ||
| Pubmed | 1.10e-03 | 1007 | 41 | 6 | 34597346 | ||
| Pubmed | 1.14e-03 | 1014 | 41 | 6 | 32416067 | ||
| Interaction | HLA-B interactions | 5.25e-06 | 239 | 38 | 6 | int:HLA-B | |
| Coexpression | GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP | 6.47e-06 | 199 | 35 | 5 | M7227 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN | 1.40e-04 | 199 | 35 | 4 | M9920 | |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN | 1.40e-04 | 199 | 35 | 4 | M7119 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN | 1.40e-04 | 199 | 35 | 4 | M8487 | |
| Coexpression | GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN | 1.40e-04 | 199 | 35 | 4 | M4147 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 1.40e-04 | 199 | 35 | 4 | M9255 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 1.40e-04 | 199 | 35 | 4 | M6932 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_DN | 1.43e-04 | 200 | 35 | 4 | M3379 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN | 1.43e-04 | 200 | 35 | 4 | M4638 | |
| Coexpression | TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE | 1.55e-04 | 78 | 35 | 3 | M41196 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 182 | 36 | 4 | a00abff41c12b71d5860c494b8c722d649fd5f36 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 182 | 36 | 4 | 626aabfd9ac662c1d189f7c4b660482914d9e669 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-05 | 190 | 36 | 4 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | COVID-19_Severe-Plasmablast|COVID-19_Severe / disease group, cell group and cell class | 1.74e-05 | 193 | 36 | 4 | 8074bcede261b85f9ae03ee372bd6d4b40384537 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 194 | 36 | 4 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | PBMC-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-05 | 194 | 36 | 4 | bd2c53fb064edfec76abe56a9ffaced0bda32ab0 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 194 | 36 | 4 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.92e-05 | 198 | 36 | 4 | e84c5f712e1dea548d0e2aba6625598f9671d3a0 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 2.94e-04 | 161 | 36 | 3 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, Lineage and Cell Type | 2.94e-04 | 161 | 36 | 3 | 8ca34d800551cb0f796293e6bfdcbf58509cc668 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 3.16e-04 | 165 | 36 | 3 | 1776e7db80d7cf6b449fa8635a111705a59231b4 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-04 | 165 | 36 | 3 | 9e2fa634f4749e35aa5dca43476477b5d362afd7 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 166 | 36 | 3 | 4b31d2755108b2815316411a38bfb11fd30ef98a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 167 | 36 | 3 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 167 | 36 | 3 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 168 | 36 | 3 | ca0c4a819f9047fc40d224f7656fec60f6fa05d8 | |
| ToppCell | droplet-Fat-Gat-18m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | 5185187ecf26b4c9eaa0c01ad52697ab8d075cc7 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.45e-04 | 170 | 36 | 3 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.51e-04 | 171 | 36 | 3 | c3e3ea09c73050372314a89b282e36ba5f339d73 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 3.63e-04 | 173 | 36 | 3 | 783b8fa08b9d8f597f251793eae164151662f1f9 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 173 | 36 | 3 | 68bcc0eee15df9cf3516c641709154301bd7b38f | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | 3f4277763e312b46ebd4401ea4a2f5d4c850c768 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | fad66d1a8407574b6a835e0bdb824a53afa58650 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-04 | 175 | 36 | 3 | 28b29f844fa46fe579ddc19039fb2d9dc5f48f3b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-04 | 175 | 36 | 3 | ac96ca9ca309b0d72a2f5af6a3b02c7f80755750 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.82e-04 | 176 | 36 | 3 | dde46f06f6fc3f7ba83be91a0ee6231790955e3e | |
| ToppCell | Adult-Immune-B_cell|Adult / Lineage, Cell type, age group and donor | 3.82e-04 | 176 | 36 | 3 | 4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.88e-04 | 177 | 36 | 3 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.95e-04 | 178 | 36 | 3 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.95e-04 | 178 | 36 | 3 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | NS-critical-LOC-Lymphoid-PC|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.01e-04 | 179 | 36 | 3 | c044478525b8e7eedecddb924c1b049331180cb2 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-04 | 179 | 36 | 3 | ba7744b903abfc28b39a00472661f152e9ae39fd | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 180 | 36 | 3 | 711719219bcbafdd505790eda895e7a33f21bed2 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 180 | 36 | 3 | b51b10781082bc0305ba6a81e978729b329f7771 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 181 | 36 | 3 | f1d88b83a13acd1c8e6b9ff8bd0acaff3650ceef | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-04 | 181 | 36 | 3 | 70cd612706640d8ebf0e047582b1daa2c1121526 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Lymphocytic-B_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-04 | 182 | 36 | 3 | 97f393549c7718a32af55b2377801bfebb10cc52 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_small-bowel / Manually curated celltypes from each tissue | 4.28e-04 | 183 | 36 | 3 | ab5aaafcfd7b97330be6774be4c72611ca85257c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B-Naive_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 4.28e-04 | 183 | 36 | 3 | be294d22b91dbcf1e8d22e6a31c39b5caaad4751 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B_plasma|GI_small-bowel / Manually curated celltypes from each tissue | 4.28e-04 | 183 | 36 | 3 | 193bfb787c1b36c8fabf4b00fafb5b398de6b999 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.35e-04 | 184 | 36 | 3 | eb41dce59eb0384c1671fbc76eb15daab2c8c49a | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | 4.35e-04 | 184 | 36 | 3 | 6f70d8f8ab8362d51f8a58735d42223e06566397 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 184 | 36 | 3 | b12fb85a064f715a4f0ada1df8e422c359b573cf | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-B_cell-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.35e-04 | 184 | 36 | 3 | 991500a874c5dd0d9111399520071da67bc6ac3d | |
| ToppCell | facs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 185 | 36 | 3 | e1fd0a807def8c2127194108b1a30c6de7024292 | |
| ToppCell | critical-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.42e-04 | 185 | 36 | 3 | 4a5d1d0a757f1f4fdb911be96ed90b52182c25f0 | |
| ToppCell | BL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.49e-04 | 186 | 36 | 3 | 27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.49e-04 | 186 | 36 | 3 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 | |
| ToppCell | mild-Lymphocytic-Plasmablast|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.49e-04 | 186 | 36 | 3 | 060510c21b1e0889b7a6eeb15821b9e2f03a0f99 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.56e-04 | 187 | 36 | 3 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.56e-04 | 187 | 36 | 3 | 160e5f338537d90d50f863a1be801b1071ac7da7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.56e-04 | 187 | 36 | 3 | d2296f2722a24b289fed7e6cfdc2105608437c3e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.56e-04 | 187 | 36 | 3 | 06a0f0a27569af89f86ed8cddb608454a3d40cc5 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 4.63e-04 | 188 | 36 | 3 | c7b1807c96f87fbcd37739a159cf00f9a1ff5d71 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasmablasts|bone_marrow / Manually curated celltypes from each tissue | 4.63e-04 | 188 | 36 | 3 | 4caae2acd9ec0eb79b7476a1e59f30f39afddcda | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.63e-04 | 188 | 36 | 3 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.63e-04 | 188 | 36 | 3 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.63e-04 | 188 | 36 | 3 | 8cf135da4d1d2500755d2809d60b41509af9fa8b | |
| ToppCell | Severe_COVID-19-B_cell|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.70e-04 | 189 | 36 | 3 | 59ce8f15f413557d2059ee6b53ba5957b864cb8e | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-04 | 189 | 36 | 3 | d1bd3b5ac32459929e556fb3a4fe8e1e15f6e658 | |
| ToppCell | mild-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.70e-04 | 189 | 36 | 3 | db2097e6e165004d47ed504e115083a4e4f4b147 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma|bone_marrow / Manually curated celltypes from each tissue | 4.70e-04 | 189 | 36 | 3 | dceb011216deb4ffd830144a53c635c05dff5ec5 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-04 | 189 | 36 | 3 | 0994aba7a44577a8943af237c9c3575502d0584c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.78e-04 | 190 | 36 | 3 | a7498fe55b7810c482291db782dc5282675d246a | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.78e-04 | 190 | 36 | 3 | a21d0c574abf21e7cb865a21a48f29c92d055fbe | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-04 | 190 | 36 | 3 | 60bb6aaea9691d07295f61c14d1650f5041a0f9c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-04 | 190 | 36 | 3 | f85cdd79eefd699ada7a91bf4997cc730a9b9846 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.85e-04 | 191 | 36 | 3 | 3fc16e986aff5e0cd4f831e25e78a5b30beba7a8 | |
| ToppCell | COVID-19_Moderate-Plasmablast|World / disease group, cell group and cell class | 4.85e-04 | 191 | 36 | 3 | bb28703020c5296b65527094d2e5924348275e58 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-04 | 191 | 36 | 3 | 208cd307826b5af89f8f10c0c915f90f80a25c6c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-04 | 191 | 36 | 3 | dd1d38a531a272a746c16807688013d29cab823a | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.85e-04 | 191 | 36 | 3 | 6729b71fb674aea770a4a3167ccfc07acbf9f302 | |
| ToppCell | severe-Lymphocytic-Plasmablast|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.85e-04 | 191 | 36 | 3 | 73660d762c9d451980c21adc426db6670bcaf37f | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-B_cell-B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.85e-04 | 191 | 36 | 3 | f9fed8dbc4e4e34e59d8c4154e4e3fb320b12257 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-04 | 191 | 36 | 3 | fca19f2719806f3dc2dd2add7252ab1198548f4d | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.85e-04 | 191 | 36 | 3 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | remission-Plasmablast|remission / disease stage, cell group and cell class | 4.92e-04 | 192 | 36 | 3 | 4bcf22061905177ad8625b87be2fbca9bff03ec6 | |
| ToppCell | COVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class | 4.92e-04 | 192 | 36 | 3 | 3d0240491296757b3125f6e861bbaca06bbc5068 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-04 | 192 | 36 | 3 | 5d6569b0f879729aa89d4498c9c886ac9050be13 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 4.92e-04 | 192 | 36 | 3 | fa99243ff028498c6a67d207a93e02c48e69cd42 | |
| ToppCell | COVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class | 4.92e-04 | 192 | 36 | 3 | 90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb | |
| ToppCell | COVID-19_Moderate-Plasmablast|COVID-19_Moderate / disease group, cell group and cell class | 4.92e-04 | 192 | 36 | 3 | 25c6c7a244190f82c7feab874bdec12490b7de4d | |
| ToppCell | COVID-19_Severe-Plasmablast|World / disease group, cell group and cell class | 4.92e-04 | 192 | 36 | 3 | a333053fe2bd206c32790916bfc5fce904ab7f57 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 193 | 36 | 3 | 3038ed3e53d3367136fac5c9773cd5b7414f49d3 | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.00e-04 | 193 | 36 | 3 | c5925b3b5d19098e3987789d68a493d7fd548ac9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.00e-04 | 193 | 36 | 3 | 902dea0bf6c2997d8b877ae01113460e511a364a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-04 | 193 | 36 | 3 | 239f2ac64f63d4d65997ba83b932a1fab1909efb | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.00e-04 | 193 | 36 | 3 | ddc06227f2580774d9f34729dff912d6a9155f9c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-04 | 193 | 36 | 3 | 2790b245d6052063c207087b91fb9375a0e8055d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.00e-04 | 193 | 36 | 3 | 94daa8a5d23558998fe3bff585344e22ce679f2d | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.00e-04 | 193 | 36 | 3 | a808eb426b4ce9ddf7d6556b083abd9232a218b1 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.00e-04 | 193 | 36 | 3 | 227d82059a9f99937e0188ff57f2d0e485ebfe69 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.00e-04 | 193 | 36 | 3 | 33dad901e0597f0057edc2bfbd64fd81f298b94e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.00e-04 | 193 | 36 | 3 | 38bb14df7f05c29565a1c7f175fafe636e543bf8 | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.00e-04 | 193 | 36 | 3 | 6905de261d90dfe3dd2c2cf5b2e26afb2bcc3d5b | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.00e-04 | 193 | 36 | 3 | f73630725f093c646bdaf178c39505c04a16e2c6 | |
| ToppCell | remission-Plasmablast|World / disease stage, cell group and cell class | 5.00e-04 | 193 | 36 | 3 | d62617c72863642f2222f7ed28bc6b90ee09b4e0 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-B_cell-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.00e-04 | 193 | 36 | 3 | e1d0b2d2d6b65d32922e22d092848ac4200669d5 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 193 | 36 | 3 | f92bbe70e6c725bfb8c08bfc2a94e375528151a3 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-04 | 193 | 36 | 3 | ce3873ece35fd2155ea235cb3c8bcd235cc0ebde | |
| Computational | Neighborhood of EIF3S2 | 2.67e-04 | 246 | 26 | 5 | MORF_EIF3S2 | |
| Computational | Neighborhood of BUB3 | 4.62e-04 | 277 | 26 | 5 | MORF_BUB3 | |
| Computational | Neighborhood of GNB1 | 7.17e-04 | 305 | 26 | 5 | MORF_GNB1 | |
| Computational | Spliceosome. | 7.48e-04 | 17 | 26 | 2 | MODULE_388 | |
| Disease | Hepatitis, Toxic | 1.30e-03 | 404 | 35 | 4 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 1.30e-03 | 404 | 35 | 4 | C4279912 | |
| Disease | Drug-Induced Liver Disease | 1.30e-03 | 404 | 35 | 4 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 1.30e-03 | 404 | 35 | 4 | C3658290 | |
| Disease | Chemical and Drug Induced Liver Injury | 1.30e-03 | 404 | 35 | 4 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 1.30e-03 | 404 | 35 | 4 | C1262760 | |
| Disease | IGA glomerulonephritis | 2.17e-03 | 58 | 35 | 2 | EFO_0004194 | |
| Disease | rheumatoid arthritis, COVID-19 | 2.63e-03 | 64 | 35 | 2 | EFO_0000685, MONDO_0100096 | |
| Disease | Dermatitis, Allergic Contact | 2.88e-03 | 67 | 35 | 2 | C0162820 | |
| Disease | Cardiac Hypertrophy | 4.28e-03 | 82 | 35 | 2 | C1383860 | |
| Disease | Cardiomegaly | 4.28e-03 | 82 | 35 | 2 | C0018800 | |
| Disease | psoriatic arthritis | 4.80e-03 | 87 | 35 | 2 | EFO_0003778 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVPFPPLIRAVTWMD | 106 | O71037 | |
| YVPFPPLIRAVTWMD | 106 | Q902F8 | |
| YVPFPPLIRAVTWMD | 106 | Q9UKH3 | |
| VLEYPMQQWRLLPYL | 346 | O15254 | |
| MEQYEVVLPWRLPGP | 26 | P78325 | |
| LDWQMVFLQKYPPPL | 456 | P25098 | |
| MEPREPWVEQEGPQY | 66 | P30511 | |
| PFEVLLRMLYPRVWP | 451 | Q8N9V6 | |
| IVWRIEPGPYFMEPE | 121 | Q9P2P5 | |
| VRDYPQVPKWMEPAI | 131 | Q8NBL1 | |
| FQWVKLPATMPEPVY | 351 | Q6PID8 | |
| IQNAAFMYPPNPWRE | 786 | O94806 | |
| ALALQLVMRYWEPIP | 106 | Q8IXM6 | |
| LQHYINPEPMRILEW | 251 | Q9BRR3 | |
| MTLWNGVLPFYPQPR | 1 | Q1HG44 | |
| LIYDRIYDWMPEQPN | 606 | Q9NPB8 | |
| RYDPRFNSWIQLPPM | 396 | Q9P2G3 | |
| YVPFPPLIRAVTWMD | 106 | P61570 | |
| YVPFPPLIRAVTWMD | 106 | Q69384 | |
| YPFLDFMPSPQVVRW | 126 | P43251 | |
| PYEDIPVQPLPMWRS | 321 | Q68D51 | |
| VDVMPWLQYFPNPVR | 241 | Q16678 | |
| YVPFPPLIRAVTWMD | 106 | Q902F9 | |
| ILDWQPPEVIQKYMP | 71 | Q9UDX4 | |
| KLWFPRFMNVNPFPV | 201 | Q9BQ95 | |
| ELNPWPEYIYTRLEM | 46 | P26639 | |
| TAWPYFLPMLNRQDP | 121 | Q9UI12 | |
| RVEPEWYIPIIPMVL | 856 | Q02880 | |
| GPFRWRDQMPPSYLL | 1596 | A0AVI2 | |
| EGIPVMRPLWVQYPQ | 721 | Q14697 | |
| WPNPLQYYLVPDMDD | 236 | P0DME0 | |
| WPNPLQYYLVPDMDD | 226 | Q01105 | |
| QPFYILKPQMPWELW | 291 | P15907 | |
| PPDRRWQYLLMAAEP | 161 | Q15428 | |
| VYQISELIFPPLPMW | 171 | Q14201 | |
| MPMPWEQIRDVPVLY | 106 | Q6P2Q9 | |
| WMQRNLQDPFYPRGP | 181 | Q96EI5 | |
| NDLMQYPVFPWILAD | 2721 | Q8IZQ1 | |
| IIWMPQELDAFQPYP | 146 | Q9Y6J8 | |
| IMAIAPWIRIPYPCQ | 296 | Q9UHI7 | |
| PPFQRLIQPEEMWLY | 31 | Q8NEB5 | |
| LIQPEEMWLYRNPYV | 36 | Q8NEB5 | |
| YPRRTPLQHEAPLWM | 486 | Q9H857 |